DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0

Similar documents
Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

1/15/2018. Disclosures. Current Diabetes Medications. Objectives NON-INSULIN AGENTS. Diabetes Med Classes. Mealtime

Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018

Diabetes Treatment Guidelines

Clinical Pharmacotherapeutic Applications of the American Diabetes Association Standards of Care 2018

Collaborative Practice Agreement

Pharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix

RPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics

Diabetes Mellitus II CPG

STEP THERAPY CRITERIA

3. Cardiovascular Disease?

Clinical Cases in Diabetes Management. Joseph Cook D.O.

Pharmacologic Agents for Treatment of Type 2 Diabetes

Physician Drug Reference Chart for Diabetes Antidiabetic Medications

Managing Complex Diabetes Cases: Medication Update. Celia Levesque MSN, RN, CNS-BC, CDE, BC-ADM

What s New in Type 2 Diabetes? 2018 Diabetes Updates

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Management of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism

Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA 2012 Virginia Mason Medical

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Very Practical Tips for Managing Type 2 Diabetes

What s New in Type 2 Diabetes? 2018 Diabetes Updates

Diabetes Medications: Oral Anti-Hyperglycemic Medications

2018 Diabetes Summit Managing Diabetes: An Art and a Science

Table 1. Antihyperglycemic agents for use in type 2 diabetes

Update on Therapies for Type 2 Diabetes: Angela D. Mazza, DO July 31, 2015

Drug Therapy in Diabetes HEATHER TINGLE UK COLLEGE OF PHARMACY, PY4

Welcome to the PHASE Learning Community! October 31, 2018

Non-Insulin Diabetes Medications Summary

INSIGHTS PRACTICE INSULIN, PRIOR AUTHORIZATION, AND UTILIZATION MANAGEMENT DECEMBER 2017 DEVELOPED BY THE AMERICAN PHARMACISTS ASSOCIATION

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents

Improving Patient Outcomes with Individualized Therapy in the Management of Type 2 Diabetes

6/1/2018. Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE

Diabetes 2016: Strategies for achieving optimal diabetes control

Deaths Hospitalizations Company. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Janssen Pharmaceuticals

Antidiabetic Agents CHAPTER BIGUANIDES

Update on Diabetic Medications UMA SUNDARAM, M.D. DIABETES & ENDOCRINE ASSOCIATES APRIL 07, 2018

Clinical Practice Guidelines

Diabetes Update 2018: Challenging Transitions. Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System

Diabetes Management: A diagnostic perspective

Diabetes Update 2018: Challenging Transitions. Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System

Diabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:

Diabetes Update Bryan Heart Conference September 5, 2015 Shannon Wakeley, MD. Disclosures. Objectives 9/1/2015

Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes

Newer Therapies for Type 2 Diabetes

What s New in Diabetes Medications. Jena Torpin, PharmD

New Therapies for Diabetes Management: Hope or Headache?

Oral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action

Pharmacology. Kacy Aderhold, MSN, APRN-CNS, CMSRN

The Management of Diabetes in Primary Care Kelly Krawtz, PharmD, BCPS, BCACP

4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis

Search strategies key terms

I. General Considerations

Advanced Practice Education Associates. Endocrine

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures

Disclosures. Objectives. Bryan Cardiology Conference DM2 & Cardiovascular Outcome Trials 8/28/2017

New Therapies for Diabetes

Glycemic Management of Type 2 Diabetes. Gail Nunlee-Bland, M.D. Professor Medicine & Pediatrics Director, Diabetes Treatment Center Howard University

How to Fight Diabetes and Win. Diabetes. Medications

The Death of Sulfonylureas? A Review of New Diabetes Medications

Inpatient Glycemic Management:

HYPOGLYCEMIA MANAGEMENT IN DIABETES

Cardiovascular Impact of Medications for Treating Type 2 Diabetes

Diabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills)

Disclosures. Objectives 11/2/2015. Type 2 Diabetes Mellitus: Medication Update. Diabetes Recommendations. Main Pathophysiological Defects in T2DM

Drug Class Review Newer Diabetes Medications and Combinations

Making Sense of New DM Therapies and Technologies

Prevalence of Diabetes Mellitus Affects 9.3% of the US popularon (29.1 million people) 1 Seventh leading cause of death in the US 1

Date of Review: September 2016 Date of Last Review: September 2015

Healthy You: A Guide to Diabetes Self-Care SURVIVAL SKILLS

Let s not sugarcoat it! Update on Pharmacologic Management of Type II DM

Initiating Injectable Therapy in Type 2 Diabetes

continuing education for pharmacists

PRIOR AUTHORIZATION BYPASS Tanzeum (albiglutide) Bypass the Prior Authorization by Modifying the following Prescription Forms to the Patient's Needs

Report Writing Specifications

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

PRIOR AUTHORIZATION BYPASS Bydureon (long acting exenatide)

Glucagon-Like Peptide (GLP-1) Receptor Agonists Clinical Edit Criteria

Staying Healthy With Diabetes

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

Limitation of use: GLP-1 Analogs are not recommended for use as first-line therapy in patients inadequately controlled on diet and exercise.

Oregon Health Plan prescription benefit updates

!"#$%&%'(!)*+'(,(&)%-!'(.#!%('"./0%(( /1#).!(&2()!(((

Victoza (Liraglutide) Solution for Injection

2/17/2016. Objectives. Define. Hey Sugar! DMII Management in Hospice Care

New Medications and Prescribing Methods for Diabetic Patients

Formulary Medical Necessity Program

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014

Glucagon-like peptide-1 (GLP-1) Agonists Drug Class Prior Authorization Protocol

Halting the Rise, Newest Non- Insulin Options for Lowering A1c

Halting the Rise, Newest Non- Insulin Options for Lowering A1c

QUESTION #2 QUESTION #4

Remote attendees, please mute your phones as a courtesy thank you!

Management of Type 2 Diabetes Mellitus

Transcription:

Metformin DIABETES (1 of 5) Glucophage Glucophage XR ER $7 (500mg) $7 (500mg) $5 $5 500mg, 750mg only 500mg, 750mg only Sulfonylurea/Combinations Amaryl Glucotrol glimepiride glipizide $5 $5 Glucotrol XL glipizide ER $12 $5 Micronase, Diabeta glyburide $5 Metaglip Glucovance glipizide/metfor min glyburide/metf ormin $22 $5 $15 $5 TZD/Combinations Actos pioglitazone $10 $5 must fail Duetact pioglitazone/ glimepiride $122 $5 ACTOplus met pioglitazone/m etformin $55 $5 must fail

DIABETES (2 of 5) DPP-4 Inhibitors/Combinations Januvia sitagliptin $469 $25 $25 Tradjenta linagliptin $338 $25 $25 Kombiglyze XR saxagliptin/metf ormin ER $394 $50 GLP-1 Mimetic Byetta exenatide $474 (3ml) $50 Bydureon Bydureon BCise Onglyza saxagliptin $316 $50 Nesina alogliptin $172 $5 $5-$10 Kazano alogliptin/metfo $172 $5 $5-$10 rmin Janumet sitagliptin/metfo $435 $25 $25 rmin Janumet XR sitagliptin/metfo $435 $25 $25 rmin ER exenatide ER $514 (8ml) $50 $25 Victoza liraglutide $440 6ml $25 $25 Trulicity dulaglutide 99 $25 $25 Ozempic Semaglutide $773 Preferred $25 $25 ** : Trulicity, Victoza, Ozempic - trial of 30 days Januvia, Janumet, Janumet XR trial of, sulfonylurea, or insulin sensitizer. * ***: all GLP-1 memetic drugs need a, even Bydureon and Victoza which are the drugs. Non- drugs may require explaining why Bydureon and Victoza are a good choice. ***United Health : Nesina, Kazano, Trulicity, Tanzeum, --trial of Metformin 1500mg qd for 90 days

SGLT2 Inhibitors/Combinations DIABETES (3 of 5) Invokana canagliflozin $453 $25 Invokamet canagliflozin/met formin $453 $25 Invokamet XR canagliflozin/met formin $453 $25 Jardiance empagliflozin $415 $25 Synjardy empagliflozin/me tformin $415 $25 Synjardy XR empagliflozin/me tformin $415 $25 Farxiga dapagliflozin $457 $25 Xigduo XR dapagliflozin/met formin ER $457 $25 Steglatro ertugliflozin $287 $50 Segluromet ertugliflozin/metf ormin $274 $50 : - Jardiance - Only FDA approval use that is consistent with ADA or AACE guidelines for T2DM and A1C monitoring within the past 3 months. : Invokana, Invokamet, Invokamet XR - must try, sulfonylurea, or insulin sensitizer : Steglatro, Segluromet - must try, er, or Riomet wtihn past 100 days United Health : Steglatro, Segluromet --90 day trial of 1500mg/day

Insulin (Rapid-Acting) DIABETES (4 of 5) $210 10ml, Apidra glulisine $430 15ml $196 10 ml, Humalog lispro $423 15ml Pen, Vial Admelog lispro $485 vial, Novolog aspart Insulin (Short-Acting) $197 10ml, $375 15ml vial, vial, vial, vial, vial, vial - ( - ) Humulin R insulin $89 vial OTC vial only vial, vial, vial Novolin R insulin $28 Walmart OTC vial $15 vial Insulin (Intermediate-Acting) Humulin N NPH $309 15ml OTC vial, Novolin N NPH $29 Walmart OTC vial, $15 vial Insulin (Long-Acting) Lantus glargine $240 10ml, $371 15ml vial, vial, Vial, Pen vial, vial, vial, Pen, Vial vial, vial Basaglar glargine $248 Pen $5 Toujeo glargine $308 bayer Levemir detemir $189 10ml Insulin (Ultra Long-Acting) $25 Tresiba degludec??? $5

Insulin (Pre-Mixed) DIABETES (5 of 5) Humalog Mix 50/50 lispro mix $131 10ml, $841 15ml $5 vial, vial, vial Humalog Mix 75/25 Humulin 70/30 lispro mix NPH/reg mix $158 10ml, $423 15ml $90 10ml, $385 15ml Novolin 70/30 NPH/reg mix $25 Walmart OTC vial Novolog 70/30 aspart mix $240 10ml, $375 15 ml $5 OTC vial, $5 vial, $5 vial, vial, vial, vial, vial, vial vial, vial vial, vial Glucometers United Healthcare Accu-Chek Aviva Plus, Accu-Chek Compact Plus free meter* Accu-check compact plus foote Bayer Breeze 2/ Bayer Contour free meter* Freestyle Lite/ Freestyle Freedom Lite free meter* Freestyle, Freestyle Lite Freestyle Freedom Lite (kit & strips) foote Onetouch (Ultra2, Ultramini, or Verio) free meter* may One Touch Verio Sure, Fast Take, Verio, Ultra 2 strips/day Ultra 2, (no insulin) 6 Ultra Mini, strips/day Verio (insulin) - glucometer. Website and customer service both say accu-chek (AvivaPlus, Compact, Nano 100 stp/30d) and freestyle (Lite, Freedom Lite), but pharmacists tell us onetouch glucometer/lancets (verio, ultra2, ultramini) although says. *** : Accu-Chek or One Touch glucometers- call 1-800-588-4456.